One in eight men in the United States will be diagnosed with prostate cancer during their lifetime. That is the same rate at which women develop breast cancer, yet prostate cancer receives a fraction of the cultural attention, funding conversations and public urgency. In 2026 alone, an estimated 333,830 men are expected to receive a diagnosis, and more than 36,000 will die from the disease. Cases have been climbing at nearly 5% per year, making what many still dismiss as a manageable condition an increasingly serious public health concern.
What makes this particularly troubling is that most men feel nothing in the early stages. There are no obvious warning signs, no dramatic symptoms that send someone rushing to a doctor. The disease moves quietly, and by the time something feels wrong, it has often already progressed to a point where treatment becomes significantly more complicated. The combination of a silent disease, inconsistent medical guidance and a cultural reluctance among men to discuss their health openly has created a dangerous gap between risk and action.
Why so many men are not getting screened
Part of the problem is a disconnect between how men perceive their health and how they engage with the healthcare system. Many step away from routine care in their 20s and 30s and do not fully return until something forces them back. Add to that years of shifting and sometimes contradictory guidelines around prostate cancer screening, and it is no surprise that awareness remains low.
There is also a persistent myth that prostate cancer is rarely fatal, which leads men to underestimate urgency. Another misconception involves the screening process itself. Many men believe testing requires a digital rectal exam, an assumption that keeps some from scheduling an appointment at all. In reality, the primary screening tool is a PSA test, a straightforward blood draw that measures levels of prostate-specific antigen in the body. Elevated results prompt further imaging before any decisions are made about next steps. It is a simple, low-barrier process that far too few men are taking advantage of.
The push to change that
A national awareness campaign launched earlier this year by two major organizations is working to shift that dynamic. The initiative encourages men to literally check a box on their medical intake forms acknowledging family history or known risk factors. That small act opens a conversation with a doctor and can trigger earlier screening referrals. It is a deliberately accessible entry point designed to reduce friction and remove the excuses that keep men from engaging with their own health.
The campaign comes at a moment when advocates are working to reach not just men but the people around them, recognizing that women often play a significant role in encouraging the men in their lives to seek care.
Black men face even higher stakes
Prostate cancer does not affect all men equally. Black men face a one in six lifetime risk, significantly higher than the national average, and are more likely to be diagnosed at an advanced stage. Family history compounds that risk further, and awareness within Black communities remains critically important.
The story of a prominent television sportscaster who went public with his own prostate cancer diagnosis last year put a human face on these statistics. Having watched his father navigate the disease, he understood his elevated risk and chose to act on it. His subsequent surgery was successful, and he has since used his platform to encourage open conversations about men’s health, particularly among Black men who may feel cultural pressure to stay silent.
What men should do now
Experts recommend that most men begin annual PSA screenings by age 45. Those at higher risk, including Black men and anyone with a family history of the disease, should start as early as 40, or ten years before the age at which a relative was diagnosed, whichever comes first.
When caught early, prostate cancer has a cure rate of approximately 99%. Yet roughly one in four men is still being diagnosed at an advanced stage. The math is not complicated. A single blood test, a candid conversation with a doctor and a willingness to acknowledge personal risk could be the difference between a treatable diagnosis and a devastating one. The barrier to entry has never been lower. The question now is whether men are willing to take it seriously.
